Box score
Elixirgen Therapeutics, Inc.
Reported $4M sold in a new Form D filed November 13, 2025 (Baltimore, Maryland).
- Biggest raise
- $4M filed Nov 13, 2025
- League
- Bio & Health Biotechnology
- Based in
- Baltimore, Maryland
- Season rank
- #524 of 1,311 in the Bio & Health League; #3975 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-11-13 | New notice | $4M | $4M | SEC |
| 2025-04-09 | New notice | $3.6M | $3.6M | SEC |
| 2025-02-12 | New notice | $600K | $600K | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1744333.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Infinity Bio, Inc. | Bio & Health | $5M |
| 2 | Somnair, Inc. rookie | Bio & Health | $4.3M |
| 3 | Zero Point Five Therapeutics, Inc. | Bio & Health | $4.3M |
| 4 | Shuttle Pharmaceuticals Holdings, Inc. | Bio & Health | $4.2M |
| 5 | OS Therapies Inc | Bio & Health | $4.2M |
| 6 | OS Therapies Inc | Bio & Health | $3.8M |